• Explore /
  • Poster
  • / The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study.

The safety and tolerability of veliparib (V) plus capecitabine (C) and radiation (RT) in subjects with locally advanced rectal cancer (LARC): Results of a phase 1b study.

Abstract Poster

Authors

null

Brian G. Czito

Duke University Medical Center, Durham, NC

Brian G. Czito , Mary Frances Mulcahy , Dustin A. Deming , Houman Vaghefi , Gayle S. Jameson , Angela Deluca , Hao Xiong , Wijith Munasinghe , Matthew W. Dudley , Philip Komarnitsky , Kyle D. Holen , Michael Michael

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01589419

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 579)

DOI

10.1200/jco.2015.33.3_suppl.579

Abstract #

579

Poster Bd #

B23

Abstract Disclosures

Similar Posters

First Author: Michael Michael

First Author: Brian G. Czito

First Author: Paul Bernard Romesser

First Author: Paul Bernard Romesser